Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb)
NCT02847507 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 307
Last updated 2018-07-17
Summary
Study of seroprevalence of hepatitis E among HIV positive patient in Basque country, France in 2016.
Conditions
- HIV
- Hepatitis E
Sponsors & Collaborators
-
University Hospital, Toulouse
collaborator OTHER -
Centre Hospitalier de la côte Basque
lead OTHER
Principal Investigators
-
Marc-olivier Vareil, phd · centre hospitalier côte Basque
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-31
- Primary Completion
- 2018-01-31
- Completion
- 2018-01-31
Countries
- France
Study Locations
More Related Trials
-
Seroprevalence of Covid-19 in the Staff of the University Hospitals of Strasbourg
NCT05652582 ·Status: COMPLETED
-
Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for Vasculitis
NCT03693586 ·Status: COMPLETED
-
Study of the Role of Dendritic Cells in the Recurrence of Hepatitis C After Liver Transplantation. Analysis of Hepatitis C Virus (HCV) Quasispecies Evolution.
NCT00213707 ·Status: UNKNOWN
-
The Microbiome Composition in Women With Recurring Intrahepatic Cholestasis of Pregnancy (ICP)
NCT05151913 ·Status: COMPLETED
-
Seroprevalence of IgG Antibodies to SARS-CoV-2 (COVID-19) in Primary Health Care Workers and Their Household Contacts
NCT04808986 ·Status: COMPLETED ·Phase: NA
-
Prevention of Graft Reinfection After Liver Transplantation With Anti HCV Monoclonal Antibodies Identified in Chronically Infected Patients or in Patients With Resolved Hepatitis C
NCT00638144 ·Status: UNKNOWN
-
COVID-19 Sero-prevalence Health Care Workers Kinshasa
NCT04699058 ·Status: COMPLETED
-
Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple Therapy
NCT02877199 ·Status: COMPLETED
-
Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
NCT06318949 ·Status: RECRUITING ·Phase: NA
-
Is Negativity of Autoantibodies a Marker of Severity in Auto-immune Hepatitis?
NCT06761209 ·Status: RECRUITING
-
Study of Professional and Individual Factors of Covi-19 and Impact on Return to Work
NCT05616663 ·Status: RECRUITING
-
Multicenter Study Evaluating the Performance of the Assay of Anti-hinge Region Antibodies in the Diagnosis of Progressive Forms of IgA Nephropathy
NCT02526966 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Hepatitis c Virus Infection Among Rheumatological Patients
NCT03587714 ·Status: COMPLETED
-
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
NCT00160940 ·Status: UNKNOWN
-
Assessment of Endocan Serum Levels in Patients With Behcet Disease
NCT03853135 ·Status: COMPLETED
-
Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)
NCT06767605 ·Status: RECRUITING
-
Vascular Affection in Behcet Disease
NCT06280430 ·Status: NOT_YET_RECRUITING
-
Assessment of the Predictive Value of Fecal Calprotectin for the Outcome of Severe Alcoholic Hepatitis
NCT02808663 ·Status: COMPLETED ·Phase: NA
-
Autoimmune Hepatitis Cohort in China
NCT05785793 ·Status: RECRUITING
-
Search for BIO Diagnostic and Prognostic Markers in Adult VAScularitis
NCT05565885 ·Status: RECRUITING
-
Lyon Granulomatous Hepatitis Study
NCT04459897 ·Status: UNKNOWN
-
Seroprevalence of MERS-CoV IgG in Healthcare Workers
NCT02497885 ·Status: COMPLETED
-
Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint Inhibitors
NCT06470997 ·Status: RECRUITING
-
Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With Primary Immunodeficiency and Secondary Humoral Deficiency
NCT06659588 ·Status: RECRUITING
-
SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel Following mRNA COVID-19 Vaccination
NCT04880174 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA